Alex Motta of IMcoMET Testimonial

Alex Motta, CTO of #medtech company IMcoMET, discusses their patented device that collects interstitial fluid for a unique type of liquid biopsy. The company uses BMF printers for the rapid prototyping and production of small, precise parts. When engaging with investors, the topic of scalability frequently arises, but with BMF's technology, Motta can reassure them that it's not a concern.